NCT01802164

Brief Summary

In patients undergoing laparotomy, the incidence of abdominal wall related complications such as incisional hernia is very high. In particular in patients with peritonitis undergoing laparotomy the incidence of incisional hernia is up to 54.3%. Furthermore, these patients are at great risk for development of postoperative fascial dehiscence. The gold standard of abdominal wall closure is a running slowly absorbable suture irrespective of the presence of peritonitis. Implantation of an intraperitoneal mesh potentially reduces the incidence of incisional hernia. In a series of high risk patients in which we implanted non-absorbable intraperitoneal mesh prophylactically we reduced the incidence of incisional hernia down to 3.2%.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2013

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 15, 2013

Completed
14 days until next milestone

First Posted

Study publicly available on registry

March 1, 2013

Completed
Same day until next milestone

Study Start

First participant enrolled

March 1, 2013

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2015

Completed
Last Updated

June 16, 2015

Status Verified

June 1, 2015

Enrollment Period

2.1 years

First QC Date

February 15, 2013

Last Update Submit

June 15, 2015

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of patients with incisional hernia

    54 months

Secondary Outcomes (8)

  • Number of patients with facial dehiscence

    54 months

  • Mortality

    54 months

  • Number of patients with surgical site infection

    54 months

  • Number of patients with intestinal fistula

    54 months

  • Number of patients with small bowel obstruction

    54 months

  • +3 more secondary outcomes

Study Arms (2)

1

EXPERIMENTAL

Conventional abdominal wall closure with mesh implantation

Device: A non-absorbable composite mesh (Ethicon Physiomesh)

2

NO INTERVENTION

Conventional abdominal wall closure without mesh implantation

Interventions

To compare prophylactic mesh implantation to conventional abdominal wall closure in patients undergoing emergency laparotomy for peritonitis.

1

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with clinical signs of peritonitis
  • Emergency laparotomy or laparoscopy with conversion to laparotomy
  • Patients \> 18 years
  • Written informed consent

You may not qualify if:

  • Previous implanted mesh
  • Incisional hernia present
  • Small bowel obstruction without bowel resection
  • Surgery for cholecystitis
  • Inflammatory bowel disease (Crohn's disease, Ulcerative colitis)
  • Polytrauma patients
  • Pregnant women
  • Women younger than 45 years

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dep. of visceral and transplant surgery, Berne University Hospital

Bern, Canton of Bern, 3010, Switzerland

Location

MeSH Terms

Conditions

PeritonitisIncisional Hernia

Condition Hierarchy (Ancestors)

Intraabdominal InfectionsInfectionsPeritoneal DiseasesDigestive System DiseasesHerniaPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsPostoperative ComplicationsPathologic Processes

Study Officials

  • Guido Beldi, Prof. Dr. med.

    Dep. of visceral and transplant surgery; Univesrity Hiospital, Berne

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 15, 2013

First Posted

March 1, 2013

Study Start

March 1, 2013

Primary Completion

April 1, 2015

Study Completion

April 1, 2015

Last Updated

June 16, 2015

Record last verified: 2015-06

Locations